Cargando…
Antiviral efficacy of nanoparticulate vacuolar ATPase inhibitors against influenza virus infection
BACKGROUND: Influenza virus infections are a major public health concern worldwide. Conventional treatments against the disease are designed to target viral proteins. However, the emergence of viral variants carrying drug-resistant mutations can outpace the development of pathogen-targeting antivira...
Autores principales: | Hu, Che-Ming Jack, Chen, You-Ting, Fang, Zih-Syun, Chang, Wei-Shan, Chen, Hui-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298390/ https://www.ncbi.nlm.nih.gov/pubmed/30587980 http://dx.doi.org/10.2147/IJN.S185806 |
Ejemplares similares
-
Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus
por: Hu, Che-Ming Jack, et al.
Publicado: (2017) -
Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2
por: Stefanik, Michal, et al.
Publicado: (2021) -
Identification of Novel Bisbenzimidazole Derivatives as Anticancer Vacuolar (H(+))-ATPase Inhibitors †
por: Patil, Renukadevi, et al.
Publicado: (2017) -
Role of the vacuolar ATPase in the Alphavirus replication cycle
por: Schuchman, Ryan M., et al.
Publicado: (2018) -
Flexibility within the Rotor and Stators of the Vacuolar H(+)-ATPase
por: Song, Chun Feng, et al.
Publicado: (2013)